Glutaredoxin (Grx) is a glutathione-dependent hydrogen donor for ribonucleotide reductase. Today glutaredoxins are known as a multifunctional family of GSHdisulfide-oxidoreductases belonging to the thioredoxin fold superfamily. In contrast to Escherichia coli and yeast, a single human glutaredoxin is known. We have identified and cloned a novel 18-kDa human dithiol glutaredoxin, named glutaredoxin-2 (Grx2), which is 34% identical to the previously known cytosolic 12-kDa human Grx1. The human Grx2 sequence contains three characteristic regions of the glutaredoxin family: the dithiol/disulfide active site, CSYC, the GSH binding site, and a hydrophobic surface area. The human Grx2 gene, located at chromosome 1q31.2-31.3, consisted of five exons that were transcribed to a 0.9-kilobase human Grx2 mRNA ubiquitously expressed in several tissues. Two alternatively spliced Grx2 mRNA isoforms that differed in their 5 region were identified. These corresponded to alternative proteins with a common 125-residue C-terminal Grx domain but with different N-terminal extensions of 39 and 40 residues, respectively. The 125-residue Grx domain and the two full-length variants were expressed in E. coli and exhibited GSH-dependent hydroxyethyl disulfide and dehydroascorbate reducing activities. Western blot analysis of subcellular fractions from Jurkat cells with a specific anti-Grx2 antibody showed that human Grx2 was predominantly located in the nucleus but also present in the mitochondria. We further showed that one of the mRNA isoforms corresponding to Grx2a encoded a functional N-terminal mitochondrial translocation signal.
Glutaredoxin (Grx) 1 was discovered in Escherichia coli as a glutathione-dependent electron donor for ribonucleotide reductase in a mutant lacking thioredoxin (1) . Calf thymus glutaredoxin was identified as a species-specific electron donor for the calf thymus ribonucleotide reductase (2) . A homogeneous preparation of E. coli (3) and calf thymus (4) glutaredoxin catalyze rapid reduction of low molecular weight disulfides, as measured with 2-hydroxyethyl disulfide (HED) in a coupled system with NADPH, GSH, and glutathione reductase (5) . Glutaredoxins are now known to be a ubiquitous multifunctional family of GSH-dependent disulfide oxidoreductases (reviewed in Ref. 5) . Classical cellular glutaredoxins are 9 -12 kDa and contain a disulfide/dithiol in the conserved active site sequence, Cys-ProTyr-Cys (6, 7), and their three-dimensional structures (8, 9) show that they belong to the thioredoxin fold superfamily (10) .
Glutaredoxins catalyze reversible oxidoreductions involving glutathione either in dithiol reactions reducing protein disulfides, as in the catalytic mechanism of ribonucleotide reductase (11) , or in monothiol reductions of mixed disulfides with GSH. In the dithiol reaction 2 mol of GSH reduce the active site disulfide of 1 mol of oxidized glutaredoxin to the dithiol form, which reduces the protein disulfide. In the monothiol reaction, which requires only the N-terminal active site Cys residue of glutaredoxin (11, 12) , reduction of mixed disulfide with GSH in proteins or low molecular weight compounds like HED or cystine is catalyzed. Glutaredoxin can also catalyze formation of GSH mixed disulfides (13) , a process called glutathionylation that appears to play a major role in regulation of protein function and signal transduction (reviewed in Ref. 14) .
Glutaredoxins in mammalian cells (also called thioltransferase) have a growing list of functions such as reduction of dehydroascorbic acid (15) , cellular differentiation (16) , and regulation of transcription factor binding activity (17, 18) . Yeast and several other organisms contain a family of monothiol glutaredoxins (19) that appear to be particularly important for defense against oxidative stress. Glutaredoxin is also implicated in apoptosis after acute cadmium exposure (20) and protects cerebellar granule neurons from dopamine-induced apoptosis by activating nuclear factor-B via REF1 (21) .
Several organisms such as E. coli (22) and yeast (19) contain a family of several glutaredoxins. In contrast, in mammalian cells only one glutaredoxin has yet been identified. The mammalian glutaredoxins show a high level of sequence conservation (5) . The mammalian enzymes are extended at both the N terminus and C terminus compared with E. coli Grx1 and contain two additional half-cysteine residues with potential regulatory functions. The human placenta glutaredoxin cDNA (23) has been cloned, and the protein has been recombinantly expressed in E. coli (24) . The gene is located on chromosome 5q14 (25) .
We report in the present study the cloning and characterization of a novel human glutaredoxin (Grx2) that is sequence-* This research was supported by grants from the Swedish Cancer Society (961), the Knut and Alice Wallenberg Foundation, the IngaBritt and Arne Lundberg Foundation, and the Karolinska Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. related to the previously identified human Grx1. Recombinant human Grx2 expressed in E. coli showed GSH-dependent dehydroascorbate and hydroxyethyl disulfide reducing activity as previously shown for human Grx1. The protein appeared to be located in both the nucleus and mitochondria, and we were able to identify a mitochondrial translocation signal in one of the cloned cDNA isoforms. The identification of a novel human member of the glutaredoxin enzyme family will be important for understanding the physiological role of these proteins.
EXPERIMENTAL PROCEDURES
Cloning of the Human Grx2 cDNA-The expressed sequence tag (EST) library of GenBank TM was accessed via the Internet at the National Institute for Biotechnology Information. The Basic Local Alignment Search Tool (BLAST) was used to identify EST cDNA clones that encoded proteins similar, but not identical, to human Grx1 (23) . The EST cDNA clones, deposited by the Integrated Molecular Analysis of Genomes and their Expression (IMAGE) consortium (26) , were obtained from Research Genetics Inc. (Huntsville, AL). DNA sequencing was performed with the automatic laser fluorescence sequencer (Amersham Pharmacia Biotech).
Prokaryotic Expression and Purification of Proteins-We used the pET-15b vector (Novagen) to express the proteins with a polyhistidine tag at the N terminus. Oligonucleotide primers containing engineered NdeI and BamHI restriction sites were designed to polymerase chain reaction-amplify the open reading frames of human Grx1 (5Ј-GACAT-ATGGCTCAAG-AGTTTGTGAACTGC and 5Ј-GAGGATCCTTACTGC-AGAGCTCCAATCTG), Grx2a (5Ј-CTACATATGGCGGGAGCTGCGG-GAG and 5Ј-GAAGGATCCTCACTGAAATTCTTTCCTCTTA), Grx2b (5Ј-GAACATATGAACCCTCGAGATAAGCAAG and 5Ј-GAAGGATCC-TCACTGAAATTCTTTCCTCTTA), and the truncated protein Grx2⌬D41-164 (5Ј-GAACATATGGAGAGCAATACATCATCTT and 5Ј-GAAGGATCCTCACTGAAATTCTTTCCTCTTA). The DNA fragments were cloned into the NdeI-BamHI sites of the pET-15b vector. The polymerase chain reaction product of Grx2⌬D41-164 was also cloned into the NdeI-BamHI sites of the pET-24a plasmid (Novagen) to express the enzyme without the polyhistidine tag. The constructs were verified by DNA sequence determinations as described above.
The plasmids were transformed into the BL21(DE3) E. coli strain, and single bacterial colonies were inoculated in 1 liter of LB medium supplemented with 100 g/ml carbenicillin (Sigma). Human Grx1 expression was induced at A 600 of 0.8 with 1 mM isopropyl ␤-D-thiogalactopyranoside for 12 h at 27°C. The expression of all the Grx2 isoforms was induced with 1 mM isopropyl ␤-D-thiogalactopyranoside at A 600 of 0.6 for 4 h at 37°C. Cells were harvested by centrifugation at 8000 ϫ g for 20 min, and the pellets were resuspended in 50 ml of 20 mM phosphate buffer, pH 7.4, 100 mM imidazole, and 1 mg/ml lysozyme. The bacterial suspensions were sonicated and cleared by centrifugation at 12000 ϫ g for 20 min. The supernatants were filtered through a 0.45-m filter and applied onto 1-ml Ni 2ϩ Hitrap chelating columns (Amersham Pharmacia Biotech). The bound proteins were eluted with 300 mM imidazole. The Grx2⌬D41-164 in pET-24a was transformed into BL21(DE3) cells, and a single colony was inoculated in 1 liter of LB medium supplemented with 30 mg/ml kanamycin (Sigma). The expression was induced at A 600 of 0.6 for 4 h at 37°C. The purification of the untagged protein was performed as described for human Grx1 (24) . The size and purity of the recombinant proteins were analyzed by SDSpolyacrylamide gel electrophoresis (Phast system, Amersham Pharmacia Biotech) after dialysis against 50 mM Tris-Cl, 1 mM EDTA, pH 8.0. The protein concentrations were determined spectrophotometrically using the molar extinction coefficients (M Ϫ1 cm
Ϫ1
) of 3160 for Grx1, 6880 for Grx2a, and 13850 for Grx2b (27) .
Enzyme Assays-The enzymatic activity was determined as previously described (4, 5) by measuring the reduction of 0.7 mM HED (Aldrich) by 1 mM GSH (Sigma) in the presence of NADPH (Sigma) and yeast glutathione reductase (Sigma) at 25°C. The decrease in NADPH was monitored at 340 nm using a molar extinction coefficient of 6200
. One unit was defined as the oxidation of 1 mol of NADPH per min. HED was substituted with either dehydroascorbate or insulin for assaying the reductase activity with these substrates.
Oxidation of Grx1 and Grx2 by Glutathione Disulfide (GSSG)-Human 6xHis-Grx1 and 6xHis-Grx2⌬D41-164 were incubated with 10 mM dithiothreitol for 30 min at 37°C to fully reduce the enzymes. The enzymes were desalted by Sephadex G25 gel chromatography. Subsequently, the enzymes were oxidized by a 100-fold molar excess of GSSG for 1 h at 4°C and desalted again. Enzyme aliquots were removed after each desalting step and analyzed for HED reductase activity.
Northern Blot Analysis-cDNA probes of Grx1 (base pairs 64 -384) (23) ; DuMedical) (Prime-A-Gene, Promega). The Grx probes and a control glyceraldehyde 3-phosphate dehydrogenase probe (CLONTECH) were hybridized to a human multiple tissue Northern blot with poly(A) ϩ RNA extracted from different tissues (CLONTECH). The hybridization was performed at 68°C in ExpressHyb solution (CLONTECH) according to the protocol provided by the manufacturer. The blot was autoradiographed using a PhosphorImager 445 SI (Molecular Dynamics, Sunnyvale, CA). The membrane was stripped from the probe in 0.1% SDS at 95°C. The removal of the probe was verified by autoradiography for an extended period of time between each reprobing.
Generation of Anti-Grx2 Antibodies-Balb-C mice were immunized by intraperitoneal injections of 50 mg of 6xHis-Grx2⌬D41-164 diluted in complete Freund's adjuvant (Sigma). After 14 days the same amount of enzyme diluted in incomplete Freund's adjuvants (Sigma) was used as a booster. Serum was collected after an additional 14 days.
Preparation of Total Cell Extract and Subcellular Fractionations-
The human cell lines U937, Jurkat, A293, HeLa, and HepG2 were obtained from the American Type Culture Collection. Human T-cell lymphotrophic virus-1-transformed T-cell line MT-4 was obtained from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). Adherent and suspension cell lines were cultured in Dulbecco's modified Eagle's medium and RPMI 1640 medium (Life Technologies, Inc.), respectively, and supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies, Inc.), 2 mM L-glutamine, and 1% penicillin and streptomycin at 37°C in 5% CO 2 .
Cells used for preparation of total cell extracts were collected by centrifugation and washed in ice-cold phosphate-buffered saline (PBS) and subsequently lysed in 50 mM Tris-Cl, pH 7.6, 1 mM EDTA, 20% glycerol, 2 mg/ml aprotinine, 0.5% Nonidet P-40. Nuclear fractions from Jurkat cells were prepared as previously described with minor modifications (28, 29) . Jurkat cells were collected by centrifugation and then washed once in PBS, and the cell pellet was suspended in two pellet volumes of buffer A (80 mM KCl, 15 mM NaCl, 5 mM EDTA, 15 mM HEPES, pH 7.4). Subsequently, the cell suspensions were mixed with two volumes of solution B (2.3 M sucrose, 1 mM dithiothreitol, 10% buffer A, 0.5 mM spermidine, 0.2 mM spermine, 1 mM phenylmethylsulfonyl fluoride), then overlaid on an equal volume of solution B, and centrifuged at 22,000 rpm for 1.5 h at 4°C. The nuclear pellet was washed with PBS and resuspended in solution A (250 mM sucrose, 1 mM dithiothreitol, 10% (v/v) buffer A, 0.5 mM spermidine, 0.2 mM spermine, 1 mM phenylmethylsulfonyl fluoride). Mitochondrial and cytoplasmic fractions of Jurkat cells were prepared as previously described (29) .
Total cell extracts and subcellular fractions were diluted (v/v) in 2ϫ loading buffer (62.5 mM Tris, pH 6.8, 2% (w/v) SDS, 10% (w/v) glycerol, 5% (w/v) 2-mercaptoethanol, 0.02% (w/v) bromphenol blue) and sonicated (Soniprep 150). Samples were separated on a 12% SDS gel and subsequently transferred onto an Immobilon-P SQ membrane (Millipore Corporation, Bedford, MA). The membranes were incubated (1 h) in blocking buffer (PBS, 2% casein, 1% bovine serum albumin, 0.05% Tween 20) and subsequently incubated for 1 h with the mouse antiGrx2 serum, followed by a 30-min incubation with the secondary antibody coupled to horseradish peroxidase (Pierce). Protein bands were visualized by enhanced chemiluminescence according to the manufacturer's recommendations (Amersham Pharmacia Biotech).
Expression of Grx2 in Fusion with Green Fluorescent Protein (GFP)-
Oligonucleotide primers were designed for Grx2a (5Ј-GCACGAGGG-GCTCTGACCATGATTTG and 5Ј-ATCCCTGAAATTCTTTCCTCTTA-CTTTTTT), Grx2b (5Ј-GAAGAATTCAGGATGAACCCTCGAGATA-AGC and 5Ј-GAAGAATCCCACTGAAATTCTTTCCTCTTAC), and Grx2⌬D41-164 (5Ј-GAAGAATTCAGGATGGAGAGCAATACATCAT and 5Ј-GAAGAATCCCACTGAAATTCTTTCCTCTTAC). The Grx2a cDNA fragment was cloned into the pcDNA3.1/CT-GFP-TOPO vector (Invitrogen) to express Grx2a fused to GFP at the C terminus. The Grx2b and Grx2⌬D41-164 DNA fragments were cloned into the EcoRIBamHI sites of the pEGFP-N1 vector (CLONTECH) to express Grx2 fused to GFP at the C terminus. The EcoRI-BamHI fragment of Grx2⌬D41-164 was also cloned into the pEGFP-C2 vector (CLONT-ECH) to express Grx2⌬D41-164 at its N terminus to GFP.
HeLa cells at 50 -70% confluence were transiently transfected with the plasmids using LipofectAMINE reagent according to the manufacturer's instructions (Life Technologies, Inc.). 24 h posttransfection the cells were contrastained with either 1 g/ml propidium iodide for 5 min at room temperature or 500 nM Mito-Tracker Red (Molecular Probes) for 30 min at 37°C. The cells were washed twice with PBS and fixed in 2.5% formaldehyde for 5 min. Cells were examined in a Leica TCS SP confocal laser scanning microscope (Leica Microsystems GmbH, Heidelberg, Germany), and images of optical sections were sampled by means of a sequential scanning procedure for GFP, Mito-Tracker Red, or propidium iodide.
RESULTS
cDNA Cloning of the Novel Human Glutaredoxin-Glutaredoxins from several species show a high level of sequence similarity (5) . We hypothesized that additional, previously unidentified human glutaredoxins may be sequence-related to the previously cloned human glutaredoxin (glutaredoxin-1, Grx1) (23) . We used the predicted amino acid sequence of this enzyme to search the EST sequence library of the GenBank TM Data Bank for EST sequences that encoded proteins similar, but not identical, to human Grx1. Two human EST cDNA clones that encoded a protein Ϸ30% identical to Grx1 were identified. The clones were derived from testis and colon cDNA libraries (IMAGE clone identifications 512859 and 731044) (26) . The first clone, named human Grx2a (GenBank TM accession number AF132495), encoded a 164-amino acid residue protein with a predicted molecular mass of 18.1 kDa (Fig. 1) . The second clone, named human Grx2b (GenBank TM accession number AF290514), contained an open reading frame having a length similar to that of human Grx2a, but the N-terminal 41 amino acid residues differed compared with Grx2a (Fig. 1) . The predicted amino acid sequence of Grx2a and Grx2b were aligned with human Grx1. The enzymes showed 34% sequence identity to human Grx1 at best alignment. Grx2a and human Grx2b were extended by 54 and 55 amino acid residues, respectively, at the N terminus and by 7 residues at the C terminus in comparison with human Grx1.
Three functional conserved regions have been described in the primary structure of glutaredoxins: the active site (CysPro-Tyr-Cys), the glutathione binding site sequence, and the hydrophobic surface area (5, 8, 9) . All three regions were identified in human Grx2 (Fig. 1) . However, the amino acids between the active site cysteine residues, which are highly conserved in known mammalian glutaredoxins (5), were different in Grx2, where the proline residue was replaced by serine. Mammalian Grx1 contains two or three cysteine residues in addition to the two active site cysteines, and these can oxidize to a disulfide and affect enzyme activity. Human Grx2 contained a total of four cysteine residues, lacking one conserved cysteine residue analogous to Cys-83 in human Grx1 (23) . In summary, the sequence similarity and conserved active site motifs of the novel protein suggested that it was a member of the glutaredoxin enzyme family.
We used the predicted amino acid sequence of human Grx-2 to identify homologous proteins from other mammals in the EST clone library of the GenBank TM . We identified eight rat (accession numbers AA848537, AW525635, AI102392, AI576512, AI101686, AI575000, AI575024, and AI574909) and seven mouse (accession numbers AA197629, AI098005, AI152248, AA396795, AA261700, AW494068, and AA261762) EST cDNA clones with high homology to human Grx2. The deduced amino acid sequences of the rat and mouse cDNA clones were aligned to obtain a consensus amino acid sequence for rat and mouse Grx2. Subsequently, the putative consensus sequence of rat and mouse Grx2 was aligned to the primary sequence of human Grx2 as shown in Fig. 1 . The alignment showed ϳ70% sequence similarity between human, rat, and mouse Grx2. The rat and mouse cDNAs were similar to the human Grx2a cDNA isoform, but no cDNA similar to the 5Ј region of the Grx2b cDNA isoform could be identified.
Expression and Characterization of Recombinant Grx2-The human Grx2 cDNAs were expressed in E. coli to verify their enzymatic activity and to compare the activity to that of the human Grx1. The recombinant proteins were expressed with an N-terminal polyhistidine tag to facilitate the purification. The full-length open reading frames of the cDNA isoforms Grx2a and Grx2b (6xHis-Grx2a and 6xHis-Grx2b), as well as an N-terminally truncated protein containing only the region conserved in the two isoforms (6xHis-Grx2⌬D41-164) (Fig. 1) , were expressed. The Grx2 isoforms were shown to have GSHdependent dehydroascorbate reductase activity as well as HED reductase activity (Table I) . However, the specific activity of all the Grx2 isoforms, determined as HED reductase activity, was Ͻ10% of the Grx1 activity. The 6xHis-Grx2a and the 6xHis-Grx2b forms showed the lowest specific activities among the expressed Grx2 isoforms. Because the specific activity as a HED reductant of all the Grx2 isoforms was at least 10-fold lower than the activity of Grx1, we tested whether this was due to the presence of the N-terminal polyhistidine tag. We expressed and purified the Grx2⌬D41-164 protein without the polyhistidine tag using the same purification protocol as de-FIG. 1. Schematic (A) and sequence (B) alignments of the predicted amino acid sequences of human Grx2a and Grx2b isoforms with rat Grx2, mouse Grx2, and human Grx1. Black boxes indicate amino acid residues conserved in at least three of the aligned sequences. The secondary structure of human Grx1 (9) and the predicted secondary structure of human Grx2 (65) are shown above the alignment. S 1 , S 2 , and S 3 indicate the active site, hydrophobic surface area, and GSH binding site, respectively. The translation start of the truncated Grx2⌬D41-164 is indicated (arrow). scribed for recombinant human Grx1 (24) . The Grx2⌬D41-164 protein exhibited a similar level of HED reductase activity both with and without the polyhistidine tag ( Table I ), suggesting that the affinity tag did not affect the enzymatic activity. Insulin was not a substrate for Grx2, which is similar to what has been observed for human Grx1 (23) . Formation of a glutathione mixed disulfide to Cys-65 in E. coli Grx3, analogous to Cys-83 in human Grx1, has previously been shown to decrease enzyme activity (45) and may be one mechanism to regulate enzyme activity in vivo. 2 Because human Grx2 lacks a cysteine at this position, we tested whether Grx2 was less sensitive to oxidation by GSSG. Reduced Grx1 and Grx2⌬D41-164 were preincubated with GSSG and then subsequently analyzed by the HED assay. The specific activity of human Grx-1 decreased nearly 50%, whereas the specific activity of Grx2⌬D41-164 was unchanged (data not shown). These findings indicate that Grx2 is more resistant to oxidation compared with Grx1.
Subcellular Localization of Human Grx2-We generated anti-Grx2 antibodies by immunizing mice with the Grx2⌬D41-164 protein. The mouse antisera used in Western blot analysis reacted with recombinant Grx2 and did not show cross-reactivity to recombinant human 6xHis-Grx1 (Fig. 2) . Neither did we detect any cross-reactivity of the mouse antibodies to Grx1 in an antibody capture assay (data not shown). The human Grx2 antibodies were used to determine the subcellular location of the native protein in subcellular fractionated Jurkat cells. Western blot analysis showed that Grx2 was predominantly detected in the cell nuclear extracts, but an apparently lower level of protein was also detected in the mitochondrial fraction (Fig. 2) . No immunoreactive protein was detected in the cytoplasmic fraction. The estimated molecular mass of Ϸ16 -18 kDa was similar in both the nucleus and mitochondrial extracts. In summary, the Western blot analysis suggested that the protein was predominantly located in the nucleus, but the protein was also located in the mitochondria.
To investigate the subcellular location of the two Grx2 cDNA isoforms, we expressed Grx2a and Grx2b in fusion with GFP to visualize the location of the proteins in vivo (see Fig. 4 ). The cells expressing Grx2a-GFP fusion protein showed a dotted fluorescence pattern that overlapped the fluorescence pattern of the Mito-Tracker Red mitochondrial dye. These findings indicated that Grx2a-GFP was localized to the mitochondria. The cells expressing Grx2b-GFP showed a dotted fluorescence pattern located predominantly in the perinuclear area of the cells, and only a weak nuclear GFP fluorescence in the area The Western blot analysis of the cytoplasmic extracts was performed on a separate membrane. To ensure equal sensitivity of the two separate blots, a Grx standard was used as an internal control.
FIG. 3. Identification of a putative mitochondrial and nuclear localization sequence of Grx2.
A, a putative N-terminal mitochondrial translocation signal (MTS) was identified in Grx2a. A possible mitochondrial prepeptidase site was also identified (arrow). A cluster of several positively charged amino acid residues, which may constitute a nuclear localization signal (NLS), was identified in the C-terminal region of both Grx2a and Grx2b. B, the predicted locations of the amino acid residues in the N-terminal part of Grx2a when folded in an ␣-helix (65).
FIG. 4. Confocal microscopy image of HeLa cells transfected with Grx2a and Grx2b fused to GFP.
HeLa cells were transfected with the Grx2a-GFP and Grx2b-GFP plasmids. 24 h posttransfection the cells were contra-stained with either Mito-Tracker Red (MT) or propidium iodide (PI) and subsequently fixed in 2.5% formaldehyde. The cells transfected with Grx2a-GFP were contrastained with MitoTracker Red (left column), and cells transfected with Grx2b-GFP were contra-stained with propidium iodide (right column). Scale bar, 20 m.
contra-stained with the propidium iodide nuclear dye was observed (see Fig. 4 ). The Grx2⌬D41-164 truncated protein fused to GFP either at its C terminus or N terminus showed a general cytosolic/nuclear fluorescence, similar to the fluorescence of cells expressing GFP alone (data not shown).
Sequence analysis of the predicted amino acid sequences of Grx2a and Grx2b isoforms suggested the presence of a putative mitochondrial translocation signal in the N-terminal region of Grx2a and a C-terminal nuclear translocation signal in both the Grx2a and Grx2b isoforms (Figs. 3 and 4) . The N-terminal region of Grx2a had a high content of positively charged and hydrophobic amino acid residues. Secondary structure prediction suggested that the region was folded into an amphipathic ␣-helical structure (Figs. 1 and 3 ). These features are common to several well characterized mitochondrial translocation signals (30) . We were also able to identify a potential mitochondrial prepeptidase cleavage site at the C terminus of the putative Grx2a mitochondrial presequence (31) . Nuclear localization signal sequences usually constitute one or two clusters of positively charged amino acid residues (32) . In the Cterminal region, present in both Grx2a and Grx2b, an arginineand lysine-rich cluster was identified that was similar to several previously described nuclear localization signals.
Genomic Organization and Chromosomal Localization of Human Grx2-We searched the high throughput genomic sequence library of GenBank TM to identify the genomic sequence of human Grx2. A yeast artificial chromosome clone containing a DNA sequence identical to that of the Grx2 cDNA was identified (clone number RP11-101E13; accession number AL136370). The clone was localized to chromosome 1q31.2-31.3. Alignment of the genomic sequence with the human Grx2a cDNA showed that the gene contained five exons distributed over Ϸ9.6 kilobase pairs (Fig. 5) . The Grx2b transcript was shown to differ in the first exon, and another exon located upstream of the Grx2a exon 1 was identified that contained a sequence identical to the 5Ј region of Grx2b (Fig. 5) . Accordingly, it is likely that alternative splicing generates the difference between Grx2a and Grx2b.
Expression Patterns of Human Grx1 and Grx2-We used a multiple tissue Northern blot analysis to determine the size and tissue distribution of the human Grx1 and Grx2 mRNA transcripts (Fig. 6 ). Grx1 mRNA was detected in all tissues as a single Ϸ0.9-kb band present in all tissues investigated. The human Grx2 probe hybridized to a major band at Ϸ0.9 kb that was detected in all tissues investigated except peripheral blood leukocytes. In addition, a larger mRNA transcript of Ϸ8 kb hybridized to the Grx2 probe in all tissues investigated.
We also determined the level of Grx2 protein in several cancer cell lines by Western blot analysis (Fig. 7) . The anti-Grx2 antibody detected a major Ϸ16 -18 kDa band in all cell lines investigated, with the highest expression level in the human T-cell lymphotrophic virus-1-transformed MT-4 cell line. DISCUSSION A growing number of organisms have been shown to have multiple glutaredoxins. In yeast five glutaredoxins have been identified (19) , and in E. coli three enzymes of the family have been identified (22) . Depending upon their active site, these glutaredoxins may be classified as dithiol glutaredoxins (CXXC) or as monothiol glutaredoxins CXXS(A). The latter class is active in catalyzing the reversible glutathionylation of proteins and may be particularly important in defense against oxidative stress (19) . Glutathione is essential in mammals (33) and yeast (34 -36) but not in E. coli (37) (38) (39) . The three E. coli dithiol glutaredoxins are well characterized but differ greatly in expression and functional properties. Grx1, which appears to be most similar to human Grx1, is highly active as an electron donor for ribonucleotide reductase, with a 10-fold lower K m value compared with thioredoxin (40), strongly up-regulated by FIG. 5 . The genomic sequence of human Grx2 isoforms and schematic illustration of the generation of the Grx2a and Grx2b cDNA isoforms. cDNAs corresponding to Grx2a and Grx2b isoforms were aligned to the genomic sequence of Grx2. The cDNAs corresponding to Grx2a and Grx2b are shown above and below the genomic sequence. Numbering of the cDNA is shown with respect to the complete nucleotide sequence. NLS, nuclear localization signal sequence; MTS, mitochondrial translocation signal.
FIG. 6. Multiple tissue Northern blot analysis of human Grx1
and human Grx2 mRNA expression. The human Grx1 probe hybridized with a mRNA species at 0.9 kb, and human Grx2 hybridized with two mRNA species at 0.9 and 8.0 kb, respectively. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control.
oxidative stress (41) by the OxyR transcription factor (42, 43) . It is also active as an electron donor for the sulfate (3Ј-phosphoadenyl sulfate) reductase (44) and has a lower redox potential (stronger reductant) compared with Grx3 (45) . E. coli Grx3 is a week electron donor to ribonucleotide reductase, and the function of this quite abundant protein is as yet relatively unknown (22, 44) . E. coli Grx2 is a highly abundant protein, with no activity with ribonucleotide reductase (22) , an atypical size of 24.3 kDa, and almost no sequence homology to the Grx1 and Grx3 (46) , but high activity with arsenate reductase in a monothiol type of reaction (47) . Evidently, the structure-function relationships in the glutaredoxin family are complex.
The identification and cloning of Grx2 in the present study showed that mammalian cells also contain a dithiol glutaredoxin enzyme family with at least two members. In previous studies, the presence of additional mammalian glutaredoxins has been suggested (48) . The level of glutaredoxin in total cell extracts of calf organs determined by enzyme activity was considerably higher than the level determined by enzymelinked immunosorbent assay (ELISA) (48) . It was speculated that the "extra" activity, especially noted in skeletal muscle and liver, was due to proteins with glutaredoxin activity. Furthermore, during preparation of glutaredoxin from human placenta, a second form of the enzyme was observed but not characterized (23) . This second form had a molecular mass similar to that of Grx1 (12 kDa) but had only Ϸ50% of Grx1 HED reducing enzyme activity. Because of the difference in size, we find it unlikely that this second form detected in placenta extracts is similar to the glutaredoxin (Grx2) reported here.
One of the major differences between human Grx1 and Grx2 is their subcellular location. The mammalian Grx1 lacks known translocation signals for transport to any subcellular compartment (23) . Immunohistochemical studies on Grx1 in calf tissues also showed predominately cytoplasmic staining, although some cells with nuclear staining were detected (49) . We showed by Western blot analysis that the human Grx2 was predominantly located in the cell nucleus, but Grx2 protein was also detected in the mitochondria. The findings suggest that Grx2 protein is present in both the nucleus and mitochondria in vivo. Other human genes, such as the human dUTPase gene (50 -52) , have been shown to encode both mitochondrial and nuclear enzyme isoforms from a single gene. The subcellular targeting of dUTPase (52) is regulated by differential RNA splicing, which will either insert or remove a 5Ј exon encoding either a nuclear or mitochondrial targeting signal. We identified two cDNA isoforms of Grx2 (Grx2a and Grx2b) that differed in their 5Ј regions. Alignment with the genomic sequence of the Grx2 gene suggested that these isoforms were generated by differential splicing. We expressed these cDNA isoforms in fusion with GFP to determine the subcellular location of the fusion proteins. The Grx2a-GFP protein was localized in the mitochondria, and the N-terminal region of the Grx2a isoform has similar properties as mitochondrial translocation signal sequences (53, 54) . The Grx2b-GFP was localized in the perinuclear region. A putative nuclear localization signal sequence was identified in the C-terminal region of both Grx2a and Grx2b isoforms (55) . However, there is no evidence that the C-terminal nuclear localization signal is functional, because the truncated mutant Grx2⌬D41-164, encoding the region conserved in both Grx2a and Grx2b without their N-terminal extensions, did not exhibit any subcellular targeting when expressed in fusion with GFP. Accordingly, these findings suggest that the perinuclear localization of Grx2b-GFP is mediated by its N-terminal region. However, we were not able to identify any similarity to known subcellular localization signal sequences in this region of Grx2b. It is likely that the perinuclear located Grx2b is the isoform detected in the nuclear subcellular fraction by Western blot analysis. However, we cannot exclude the possibility that additional Grx2 isoforms with nuclear location exist in human cells.
In the family of glutaredoxins, three conserved regions have been identified that comprise the active site (Cys-Pro-Tyr-Cys), hydrophobic surface area, and a glutathione binding site (5, 8, 9) . All three regions were identified in Grx2, demonstrating that the cloned protein belonged to the classical glutaredoxin family (Fig. 2) (5) . The amino acids between the active site cysteines in the CXXC motif have been shown to be highly conserved from prokaryotes to eukaryotes. Changes of any of these residues have been shown previously to greatly impact the redox potential and/or the catalytic activity of thioredoxins and glutaredoxins (45) . Interestingly, in Grx2 the conserved proline was changed to a serine, which may be of importance for its catalytic activity. Recombinant Grx2 isoforms expressed in E. coli were shown to have GSH-dependent HED reductase activity, but the specific activity of the purified Grx2 proteins was Ͻ10% of the Grx1 specific activity. One possibility for the generally lower specific activity of Grx2 may be that we did not use the optimal substrate (HED) or assay conditions for Grx2. Western blot analysis of subcellular fractionated cells indicated that the cells expressed relatively low amounts of Grx2.
Although glutaredoxins have the capacity to reduce protein disulfides, e.g. the catalytic mechanism of ribonucleotide reductase, they favor the reduction of glutathione mixed disulfides with low molecular weight thiols and proteins (11, 12) . Moreover, during periods of oxidative stress (decreased concentration of GSH and/or a lower GSH/GSSG ratio), glutaredoxin may form GSH mixed disulfides with proteins (13) , with the potential to inhibit various enzyme activities. Human Grx1, but not Grx2, contains an additional Cys residue, which may render Grx1 more sensitive to oxidation and inactivation. Indeed, pretreatment of Grx1 and Grx2, respectively, with GSSG induced a 50% inhibition of Grx1 activity, whereas Grx2 remained unchanged. During oxidative stress or in an environment with a lot of reactive oxygen species, like mitochondria, Grx2 may remain active and also have the ability to form GSH mixed disulfides and control their level.
A growing number of reports suggest that reactive oxygen species such as hydrogen peroxide and superoxide anions might function as intracellular messengers in receptor signal- FIG. 7 . Western blot analysis of Grx2 expression in human cancer cell lines. The human cell lines U937, A293, HepG2, and MT-4 were harvested at logarithmic growth and lysed in 50 mM Tris-Cl, pH 7.6, 1 mM EDTA, 20% glycerol, 2 mg/ml aprotinine, and 0.5% Nonidet P-40. Crude extracts (40 g of protein) were separated on 12% SDS gel and transferred onto a polyvinylidene difluoride membrane. The membrane was hybridized with the anti-Grx2 antibody and visualized by chemiluminescence.
ing (56, 57) . This will result in an oxidative stress, increasing GSSG by the glutathione peroxidase reaction, and may lead to glutathionylation of proteins as a signaling mechanism. Glutaredoxin is known to be highly effective in regenerating glutathionylated proteins (58, 59 ) and may therefore be central in signal transduction. The mitochondria are a major source of reactive oxygen species in the cell, due to electron leakage from the respiratory chain (60 -62) . In general, reactive oxygen species and other free radicals have been implicated in physiological and pathological processes of the organism, e.g. cellular signaling, cell proliferation, apoptosis, and cancer (63) . Mitochondrial glutathione plays a critical role in the maintenance of cell functions and viability and in mitochondrial physiology by metabolism of oxygen free radicals generated in the respiratory chain. Mitochondrial Grx2 may therefore potentially play an important role in the protection against radical-induced damage of mitochondrial DNA and mitochondrial proteins.
Both the nucleus and the mitochondria contain glutathione. Interestingly, nuclear GSH has been shown to be rather resistant to depletion by, e.g. buthionine sulfoximine, N-ethylmaleimide, and maleate, respectively, in comparison to the cytoplasmic GSH, suggesting that nuclear GSH is important against oxidative damage of the nuclear DNA and nuclear proteins (64) . Reactions between proteins and GSH or GSSG alone are rather slow and unspecific. During periods of oxidative stress, nuclear Grx2 may still have the capacity to catalyze GSH-dependent reactions. Redox regulation of transcription factors by glutathionylation processes has been shown to be one mechanism above phosphorylation in the regulation of the binding activity of transcription factors (18) . Because glutaredoxin has been shown to have the capacity to catalyze reversible reactions with glutathione, it may play an important role in the regulation of binding activity of transcription factors.
In summary, a new member of the mammalian glutaredoxin has been cloned with enzymatic characteristics of a glutaredoxin. In contrast to the cytoplasmic mammalian Grx1, the new Grx2 may have the ability to localize to both the nuclear membrane and mitochondria. Further experiments are being undertaken to study what stimulus determines the translocation pattern and the function of Grx2 translocated to the mitochondria and nucleus, respectively.
